Emerging prognostic factors in diffuse large B cell lymphoma.

  title={Emerging prognostic factors in diffuse large B cell lymphoma.},
  author={Randy D. Gascoyne},
  journal={Current opinion in oncology},
  volume={16 5},
PURPOSE OF REVIEW Diffuse large B cell lymphoma (DLBCL) is the most common lymphoma subtype, characterized by marked clinical and biologic heterogeneity. Gene expression studies together with new monoclonal antibody production are playing an increasing role in determining important prognostic factors/biomarkers predictive of outcome. Despite these technical advances, much confusion exists in the literature as to what constitutes the important biomarkers for determining patient outcome. The… CONTINUE READING

From This Paper

Topics from this paper.


Publications citing this paper.
Showing 1-10 of 21 extracted citations

Diffuse large B-cell lymphoma with overexpression of cyclin e substantiates poor standard treatment response and inferior outcome.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2006
View 2 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…